HENDERSON, NV, Aug. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences Inc. (OTCPK: BLFE) (the “Company” or BioLife) announced today it has engaged GS Whitney & Co. (GS Whitney) to ...

Prosper Stars & Stripes, a long/short equity fund, recently released its first-quarter 2026 investor letter. A copy of the letter is available to download here. In Q1 2026, the portfolio ...

BioLife Solns (NASDAQ:BLFS) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary of ...

BioLife is a cell- and gene-therapy bioproduction tools and services company. It makes cell-storage media, thawing solutions, cold chain accessories, and cryopreservation freeze media products. Its ...

The MarketWatch News Department was not involved in the creation of this content. Fourth quarter unaudited revenue from continuing operations of $24.8 million increased 20% from the prior year fourth ...

Plasma donation and testing company BioLife Plasma Services LP in has invested $4 million to expand its testing laboratory in Hoover, Ala., and buy equipment to recycle biohazardous plastics waste ...

Image source: The Motley Fool. BioLife Solutions (NASDAQ:BLFS) reported 25% revenue growth and higher adjusted EBITDA, driven principally by its biopreservation media franchise and increased sales to ...

Exclusive global supplier of non-toxic, non-flammable PCM; first to operate at -70°C, meeting critical temperature requirement of biologic materials. "We are excited to provide more value to our life ...

BioLife CEO Bill Jones calls for a new global health vocabulary, shifting from weight-loss language to biology-driven terms that support metabolic well-being, body positivity, and regenerative care.

BioLife makes bio preservation tools for cells and tissues for the gene therapy market. Along with its second-quarter earnings report, it said it plans to divest itself of its Stirling Ultracold and ...